News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Draupnir Bio Raises €12 Million in Seed Funding to Further Develop Oral Small Molecule Degraders Targeting Extracellular Proteins
Thursday, July 18, 2024Draupnir Bio a biotechnology company has raised million in equity investments to advance its innovative approach in targeted protein degradation The company focuses on developing oral
Grünenthal Increases Investment in Latin America Production Facilities to Ensure Reliable Medicine Supply
Thursday, July 18, 2024Grnenthal a leading pharmaceutical company specializing in pain research and management has recently announced significant investments in its Latin American production sites These investments
Genomics plc and Vertex Pharmaceuticals Extend and Expand Collaboration in Drug Discovery
Wednesday, July 17, 2024Genomics plc has announced a further threeyear extension of its collaboration with Vertex Pharmaceuticals Incorporated to advance the discovery and development of precision medicines
Synamics Therapeutics Attracts Former Executives from Novozymes as Lead Investors for AI-Driven Drug Discovery
Wednesday, July 17, 2024Synamics Therapeutics a startup focused on using AI for drug discovery to combat drug resistance in cancer has received significant backing in its preseed funding round from two prominent figures
Sionna Therapeutics Expands Cystic Fibrosis Pipeline with Multiple Clinical-Stage Compounds Through Collaboration with AbbVie
Wednesday, July 17, 2024Sionna Therapeutics a company in the clinical stage of life sciences dedicated to advancing treatments for cystic fibrosis has recently secured exclusive global rights to develop
CordenPharma Plans €900 Million Investment to Enhance Peptide Platform in the USA and Europe
Tuesday, July 16, 2024CordenPharma has recently announced its largest strategic investment totaling around million over the next three years aimed at expanding its Peptide technology platform This initiative includes significant
Catalent Completes Expansion of Clinical Supply Facility Worth $25 Million in Schorndorf, Germany
Tuesday, July 16, 2024Catalent Inc has recently completed the expansion of its clinical supply facility located in Schorndorf Germany This expansion marks a significant upgrade to Catalents flagship European site adding square
Sumitomo Pharma Receives FDA Fast Track Designation for DSP-5336 in Relapsed or Refractory Acute Myeloid Leukemia Treatment
Monday, July 15, 2024Sumitomo Pharma America Inc has announced that the US Food and Drug Administration granted Fast Track designation to DSP for the treatment of patients with relapsed or refractory
Arrivo Secures FDA Fast Track Status for RABI-767 Targeting Acute Pancreatitis Patients Likely to Develop Severe Disease
Monday, July 15, 2024Arrivo BioVentures announced today that its subsidiary Panafina Inc has been granted Fast Track Designation by the FDA for RABI an investigational new drug intended for patients
Pan Cancer T Secures €4.25 Million to Advance Next-Generation T Cell Therapies in Seed Extension Round
Friday, July 12, 2024Pan Cancer T BV a biotech startup focusing on advancing T cell therapies for solid cancers has successfully closed a million Seed Extension round This funding includes
